Search

everythinglearnresearchcommunity

for

Search:↓

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Environmental factors like temperature and nutrition affect hair growth, with humans showing seasonal hair growth differences.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss from telogen effluvium may not happen again after another surgery.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The drinkable supplement reduced hair shedding and increased hair growth in women.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hair changes can indicate systemic diseases or medication effects.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

The supplement improved hair health and reduced shedding in people with telogen effluvium.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

COVID-19 infection may cause hair loss.

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Placenta products might help with hair loss, but more research is needed.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Wheat extract supplements reduce hair shedding and improve growth in women with hair loss.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.